Variable | All patients | GB cancer | Bile duct cancer | p-value | |||
---|---|---|---|---|---|---|---|
 | No. | % | No. | % | No. | % |  |
P53 (n = 127) | |||||||
   Positive | 72 | 56.7 | 32 | 61.5 | 40 | 53.3 | 0.231 |
   Negative | 55 | 43.3 | 20 | 38.5 | 35 | 46.7 |  |
Cyclin D1 (n = 131) | Â | Â | Â | Â | Â | Â | Â |
   Positive | 35 | 26.7 | 18 | 33.3 | 17 | 22.1 | 0.109 |
   Negative | 96 | 73.3 | 36 | 66.7 | 60 | 77.9 |  |
Survivin (n = 129) | Â | Â | Â | Â | Â | Â | Â |
   Positive | 54 | 41.9 | 20 | 37.7 | 34 | 44.7 | 0.271 |
   Negative | 75 | 58.1 | 33 | 62.3 | 42 | 55.3 |  |
TP (n = 120) | Â | Â | Â | Â | Â | Â | Â |
   Positive | 78 | 65.0 | 40 | 78.4 | 38 | 55.1 | 0.006 |
   Negative | 42 | 35.0 | 11 | 21.6 | 31 | 44.9 |  |
ERCC1 (n = 113) | Â | Â | Â | Â | Â | Â | Â |
   Positive | 39 | 34.5 | 18 | 36.7 | 21 | 32.8 | 0.406 |
   Negative | 74 | 65.5 | 31 | 63.3 | 43 | 67.2 |  |